Design of acyclic triaryl olefins: a new class of potent and selective cyclooxygenase-2 (COX-2) inhibitors

被引：29
|
作者：
Uddin, MJ [1 ]
Rao, PNP [1 ]
Knaus, EE [1 ]
机构：
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 08期
基金：
加拿大健康研究院;
关键词：
acyclic olefins; cyclooxygenase-2; anti-inflammatory;
D O I：
10.1016/j.bmcl.2004.01.075
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A new class of acyclic 1,1-diphenyl-2-(4-methylsulfonylphenyl)-2-alkyl-1-ethenes were synthesized, via a short two-step McMurry olefination reaction and then oxidation of the thiomethyl intermediate using Oxone(, in 62-76% yield. The title compounds possess identical C-1 phenyl substituents which precludes the possibility of (Z)- and (E)-stereoisomers. 1,1-Diphenyl-2-(4-methylsulfonylphenyl)hex-1-ene exhibited highly potent (IC50 = 0.014 muM) and selective COX-2 (Selectivity Index >7142) inhibitory activity. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1953 / 1956
页数：4
相关论文
共 50 条
  • [1] Design and synthesis of acyclic triaryl (Z)-olefins:: a novel class of cyclooxygenase-2 (COX-2) inhibitors
    Uddin, MJ
    Rao, PNP
    Knaus, EE
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (22) : 5929 - 5940
  • [2] A new class of acyclic 2-alkyl-1,2-diaryl (E)-olefins as selective cyclooxygenase-2 (COX-2) inhibitors
    Uddin, MJ
    Rao, PNP
    Rahim, MA
    McDonald, R
    Knaus, EE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (19) : 4911 - 4914
  • [3] A new class of acyclic 2-alkyl-1,1,2-triaryl (Z)-olefins as selective cyclooxygenase-2 inhibitors
    Uddin, MJ
    Rao, PNP
    McDonald, R
    Knaus, EE
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) : 6108 - 6111
  • [4] Discovery of a new class of selective cyclooxygenase-2 (COX-2) inhibitors that covalently modify the isozyme
    Kalgutkar, AS
    Crews, BC
    Marnett, LJ
    FASEB JOURNAL, 1997, 11 (09): : A1325 - A1325
  • [5] Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors
    Kalgutkar, AS
    Crews, BC
    Rowlinson, SW
    Marnett, AB
    Kozak, KR
    Remmel, RP
    Marnett, LJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 925 - 930
  • [6] Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
    Groesch, Sabine
    Maier, Thorsten Juergen
    Schiffmann, Susanne
    Geisslinger, Gerd
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (11): : 736 - 747
  • [7] Cyclooxygenase-2 (COX-2) in carcinogenesis and selective cox-2 inhibitors for chemoprevention in gastrointestinal cancers
    Fujimura T.
    Ohta T.
    Oyama K.
    Miyashita T.
    Miwa K.
    Journal of Gastrointestinal Cancer, 2007, 38 (2-4) : 78 - 82
  • [8] 3-(2-methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors
    Ranatunge, RR
    Earl, RA
    Garvey, DS
    Janero, DR
    Letts, LG
    Martino, AM
    Murty, MG
    Richardson, SK
    Schwalb, DJ
    Young, DV
    Zemtseva, IS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 6049 - 6052
  • [9] Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk
    Ashok, Varun
    Dash, Chiranjeev
    Rohan, Thomas E.
    Sprafka, J. Michael
    Terry, Paul D.
    BREAST, 2011, 20 (01): : 66 - 70
  • [10] From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors
    Black, WC
    Bayly, C
    Belley, M
    Chan, CC
    Charleson, S
    Denis, D
    Gauthier, JY
    Gordon, R
    Guay, D
    Kargman, S
    Lau, CK
    Leblanc, Y
    Mancini, J
    Ouellet, M
    Percival, D
    Roy, P
    Skorey, K
    Tagari, P
    Vickers, P
    Wong, E
    Xu, L
    Prasit, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) : 725 - 730
12345